在非男性因素不孕症中,与常规授精相比,卵胞浆内单精子注射没有获益,表现为整倍体率相当
这项回顾性队列研究纳入2014年1月至2021年12月期间3554例接受体外受精且行PGT-A的患者,比较卵胞浆内单精子注射(ICSI)与常规授精(CI)的胚胎整倍体率。ICSI组整倍体率显著低于CI组(0.47 vs 0.52),整倍体率比为0.89;调整PGT参考实验室后关系不再显著(率比=0.97)。作者认为ICSI不提供任何获益,支持CI作为非男性因素不孕症的首选授精方法。
要点
- ICSI组每枚活检胚胎的整倍体率显著低于CI组(0.47 vs 0.52),整倍体率比为0.89。
- 调整PGT参考实验室后,ICSI与整倍体率的关系不再显著(率比=0.97)。
- 作者认为在非男性因素不孕症中ICSI不提供任何获益,支持CI作为首选授精方法。
核心结论
- 在非男性因素不孕症中,ICSI导致较低的受精率和比CI低11%的胚胎整倍体率;尽管调整PGT参考实验室后数据无统计学显著性,作者仍认为ICSI不提供任何获益。
- 这些数据支持CI应作为非男性因素不孕症病例的首选授精方法。
研究设计与样本
- 回顾性队列研究,纳入2014年1月至2021年12月期间在美国一个学术附属不孕症中心接受体外受精周期的3554例患者。
- 纳入所有通过滋养层活检进行胚胎植入前非整倍体检测(PGT-A)且制备后精子浓度>4百万总活动精子/毫升的周期。
- 使用泊松分布的广义估计方程估计整倍体率比(以总活检胚胎数为偏移量),并考虑每位患者多次取卵。
- 使用14项基线女性和男性特征为ICSI拟合倾向性评分模型以调整混杂。
主要发现
- 两组取卵数和活检胚胎数相似,但ICSI组每取卵的受精率显著低于CI组(0.64 vs 0.66)。
- ICSI组整倍体胚胎比例显著低于CI组(0.47 vs 0.52),整倍体率比为0.89。
- 调整手术日期未改变ICSI与整倍体率的关系(率比=0.89);调整PGT参考实验室后,ICSI与整倍体率的关系不再显著(率比=0.97)。
临床怎么用
- 作者认为在非男性因素不孕症中ICSI不提供任何获益,这些数据支持CI应作为首选授精方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether differences in euploidy rates exist between intracytoplasmic sperm injection (ICSI) and conventional insemination (CI) in nonmale factor infertility cases. DESIGN: Retrospective cohort study. SETTING: A single, academically affiliated infertility center in the United States. PATIENTS: A total of 3554 patients who underwent in vitro fertilization cycles from January 2014 to December 2021. All cycles that had preimplantation testing for aneuploidy (PGT-A) performed by trophectoderm biopsy and had a postpreparation sperm concentration >4 million total motile sperm per milliliter were included. MAIN OUTCOME MEASURES: The primary outcome was the embryo euploidy rate per embryo biopsied in the ICSI vs. CI group. Secondary outcomes included the fertilization rate and number of embryos biopsied. Generalized estimating equations with a Poisson distribution were used to estimate the euploid rate ratio (with total embryos biopsied as an offset), while accounting for multiple retrievals per patient. To adjust for confounding, a propensity score model was fit for ICSI using 14 baseline female and male characteristics. RESULTS: Oocytes retrieved and the number of embryos biopsied were similar in both groups, while the fertilization rate per oocyte retrieved was significantly lower with ICSI (0.64 vs. 0.66). The proportion of euploid embryos in the ICSI group was significantly lower when compared with CI (0.47 vs. 0.52), with a euploid rate ratio of 0.89. Interestingly, when accounting for the variation in PGT reference laboratories over the study time period, adjusting for the date of procedure did not change the relationship between ICSI and euploid rate (rate ratio = 0.89); however, after adjusting for the PGT reference laboratory, the relationship between ICSI and euploid rate was no longer significant (rate ratio = 0.97). CONCLUSIONS: In the setting of nonmale factor infertility, ICSI resulted in a lower fertilization rate and an 11% lower embryo euploid rate compared with CI. Although the data are not statistically significant when adjusted for the PGT reference laboratory, we still can conclude that ICSI does not provide any benefit. These data support the recommendation that CI should be the preferred methodology for fertilization in nonmale factor infertility cases.
引用
- Patel K, Vaughan DA, Rodday AM, et al. Compared with conventional insemination, intracytoplasmic sperm injection provides no benefit in cases of nonmale factor infertility as evidenced by comparable euploidy rate. Fertil Steril. 2023. PMID: 37085098. doi:10.1016/j.fertnstert.2023.04.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。